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OBJECTIVE—Insulin secretion involves complex events in
which the mitochondria play a pivotal role in the generation of
signals that couple glucose detection to insulin secretion. Studies
on the mitochondrial generation of reactive oxygen species
(ROS) generally focus on chronic nutrient exposure. Here, we
investigate whether transient mitochondrial ROS production
linked to glucose-induced increased respiration might act as a
signal for monitoring insulin secretion.
RESEARCH DESIGN AND METHODS—ROS production in
response to glucose was investigated in freshly isolated rat islets.
ROS effects were studied using a pharmacological approach and
calcium imaging.
RESULTS—Transient glucose increase from 5.5 to 16.7 mmol/l
stimulated ROS generation, which was reversed by antioxidants.
Insulin secretion was dose dependently blunted by antioxidants
and highly correlated with ROS levels. The incapacity of -cells
to secrete insulin in response to glucose with antioxidants was
associated with a decrease in ROS production and in contrast to
the maintenance of high levels of ATP and NADH. Then, we
investigated the mitochondrial origin of ROS (mROS) as the
triggering signal. Insulin release was mimicked by the mitochon-
drial-complex blockers, antimycin and rotenone, that generate
mROS. The adding of antioxidants to mitochondrial blockers or
to glucose was used to lower mROS reversed insulin secretion.
Finally, calcium imaging on perifused islets using glucose stim-
ulation or mitochondrial blockers revealed that calcium mobili-
zation was completely reversed using the antioxidant trolox and
that it was of extracellular origin. No toxic effects were present
using these pharmacological approaches.
CONCLUSIONS—Altogether, these complementary results
demonstrate that mROS production is a necessary stimulus for
glucose-induced insulin secretion. Diabetes 58:673–681, 2009
E
lucidating the mechanisms by which pancreatic
-cells couple glucose sensing to insulin secre-
tion, a vital process in energy homeostasis, is of
prime importance. Although ATP production is
considered the main mitochondrial signal, detailed studies
show that insulin secretion cannot be restricted to ATP
synthesis, and numerous experimental clues show that
additional mitochondrial factors involved in glucose-secre-
tion coupling are necessary, although not yet identiﬁed (1).
Transient increases in glucose metabolism generate
NADH and FADH2, leading rapidly to increased superox-
ide anion (O2
) production; obligatorily associated with the
respiratory chain function, superoxide anion will be con-
verted into H2O2 (2). This production of mitochondrial
reactive oxygen species (mROS)—transient because H2O2-
inactivating enzymes rapidly quench it before a damage to
the physiological conditions of the cell occurs—is now
recognized as an intracellular messenger (3,4). These
features make mROS a good candidate for rapidly regulat-
ing pathways that depend directly on metabolic ﬂuxes.
Based on such a view, we recently demonstrated that
mROS production is required for hypothalamic glucose
and lipid sensing (5,6). These results lead us to speculate
that O2
 might operate more generally in nutrient-sensitive
cells and also to look for the role of mROS as a signal
involved in glucose-stimulated insulin secretion (GSIS).
Recently, a study revealed that H2O2 is effectively a signal
of GSIS (7). Here, we provide clues that glucose-induced
mitochondrial O2
 production is an obligatory stimulus for
insulin secretion.
RESEARCH DESIGN AND METHODS
Male Wistar rats, weighting 250–300 g, were maintained in animal quarters at
a constant temperature (21–23°C) and with a 12-h light/12-h dark cycle. Food
and water were available ad libitum. All rats were treated in accordance with
European Community guidelines, and our local institution approved the
experimentation. Pharmacological agents were all purchased from Sigma-
Aldrich, except carbonyl cyanide m-chlorophenylhydrazone (CCCP), which
was obtained from Calbiochem.
Islet isolation. Rats were anesthetized using pentobarbital (4 mg/100 g body
wt i.p.; Sanoﬁ Sante ´ Animale, Libourne, France). Islets of Langerhans were
isolated after collagenase digestion of the pancreas, as previously described
(8). Brieﬂy, the pancreatic duct was ligated distally and injected with an
ice-chilled solution of collagenase (Type V collagenase; Sigma) and 5.5 mmol/l
glucose in Hank’s balanced salt solution (HBSS; 137 mmol/l NaCl, 5.36 mmol/l
KCl, 4.17 mmol/l NaHCO3, 0.88 mmol/l MgSO4, 0.44 mmol/l KH2PO4, 0.34
mmol/l Na2HPO4, 1.27 mmol/l CaCl2, 10 mmol/l HEPES, and 0.5% BSA). The
pancreas was removed and incubated for 9 min at 37°C. The suspension was
repeatedly passed through a 14-gauge needle. After several centrifugations
and resuspensions in ice-cold HBSS, the dispersed pancreas was ﬁltered
through a 500-m screen. The ﬁltrate was pelleted and resuspended in 20 ml
Histopaque 1077 (Sigma), on the top of which 20 ml HBSS was carefully
layered. After 20 min of centrifugation at 2,500 rpm at room temperature, the
islets were recovered from the interface and washed twice in HBSS. The islets
were immediately used for static incubations or perifusion experiments.
Insulin release, ATP, NADH, and ROS evaluations under static incuba-
tion. Insulin release was measured on the islet batches in the supernatant
using radioimmunoassay. Groups of 60–80 islets were ﬁrst preincubated for
60 min at 37°C in silicone-coated glass tubes, in 1 ml Krebs-Ringer bicarbonate
HEPES buffer (KRBH) buffer supplemented with 5 mg/ml BSA (fraction V;
Sigma) and 2.8 mmol/l glucose. For the ﬁrst 15 min of preincubation, the tubes
were gassed with a mixture of O2:CO2 (95%:5%). Over the preincubation
period, the medium was eliminated and replaced with 1 ml KRBH-BSA
medium [KRBH buffer (140 mmol/l NaCl, 3.6 mmol/l KCl, 0.5 mmol/l NaH2PO4,
0.5 mmol/l MgSO4, 2 mmol/l NaHCO3, 1.5 mmol/l CaCl2, and 10 mmol/l HEPES)
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DIABETES, VOL. 58, MARCH 2009 673and 1% BSA (fraction V; Sigma)] containing the different glucose concentra-
tions and/or pharmacological agents 1 mmol/l trolox, 100 mol/l rotenone, 20
mol/l antimycin, 1 mmol/l glutathione ethylester, and 1 mol/l CCCP.
Rotenone and antimycin partially block the electron transfer in the mitochon-
drial chain (depending on concentration), favoring the reaction with molecu-
lar O2, and then increasing anion superoxide formation, which is itself being
rapidly converted into H2O2 (via the mitochondrial manganese superoxide
dismutase [MnSOD]). The islets were further incubated for 30 min at 37°C. At
the end of this period, the medium was stored at 20°C until assayed for
insulin, except for resecretion tests. The islets were sonicated, and ATP and
NADH contents were respectively determined using a bioluminescent kit
(Sigma-Aldrich) and a spectrophotometer to measure NADH through the
absorbance at 340 nm. In experiments to determine intracellular ROS, islets
were loaded with a ﬂuorescent probe that corresponds to intracellular H2O2
increase, because the probe used (CM-H2DCFDA) is a classical H2O2 marker.
The incubation was conducted as previously described (6). At the end of the
experiments, islets were rinsed and disrupted using sterile water. After a
5-min centrifugation (3,000  g), islet supernatants containing the oxidized
product ﬂuorescing due to ROS were analyzed as previously described (6).
Evaluation of insulin release during perifusion experiments. Kinetics of
insulin release in vitro were studied using the perifusion procedure already
described (8). Four columns were run at the same time, each containing
85–120 freshly isolated islets of Langerhans. The perifusion medium contain-
ing the basal buffer [2.8 mmol/l glucose in KRBH containing 140 mmol/l NaCl,
3.6 mmol/l KCl, 0.5 mmol/l NaH2PO4, 0.5 mmol/l MgSO4, 2 mmol/l NaHCO3, 1.5
mmol/l CaCl2, 10 mmol/l HEPES, and 1% BSA (fraction V; Sigma)] was
supplemented with a high glucose concentration (16.7 mmol/l) and/or the
pharmacological agents 1 mmol/l trolox (a vitamin E analog, involved in the
synergic regeneration of antioxidant defenses, such as reduced glutathione, as
well as a powerful scavenger of peroxide radicals in membranes) and 100
mol/l rotenone as needed. The perifusion ﬂuid was collected at 1-min
intervals and kept on ice until the end of the experiment. Fractions collected
were stored at 20°C until assayed for insulin.
Measurements of islet intracellular free calcium concentration. Freshly
isolated islets were loaded for 1 h with 5 mol/l Fura-2/AM at 37°C in KRBH
containing 115 mmol/l NaCl, 5 mmol/l KCl, 24 mmol/l NaHCO3, 1 mmol/l CaCl2,
1 mmol/l MgCl2, and 5.5 mmol/l glucose and 5 mg/ml BSA. After loading, eight
islets at a time were allowed to attach onto a polylysine-treated coverglass
transferred to a perifusion chamber placed on the stage of an inverted
ﬂuorescent microscope (Nikon Diaphot, Champigny sur Marne, France).
Canulas feeding into the chamber were connected to a peristaltic pump and
allowed a continuous superfusion of the islets at a ﬂow rate of 1 ml/min with
a 25 mmol/l HEPES-buffered medium maintained at 37°C containing 125
mmol/l NaCl, 5.9 mmol/l KCl, 1.28 mmol/l CaCl2, 1.2 mmol/l MgCl2, 5.5 mmol/l
glucose, and 1 mg/ml BSA. Intracellular free Ca
2 concentration ([Ca
2]i) was
determined as previously described (9,10). Brieﬂy, a selected area of the islets
was excited at 340 and 380 nm alternatively (every 2 s), and the ﬂuorescence
intensity emitted at 510 nm was measured by using a Photoscan II microﬂu-
orometer (Photon Technology International, Biotek Kontron, St. Quentin
Yvelines, France). The measurements of successive 340/380 ﬂuorescence
ratios (R) reﬂect the cytosolic free calcium concentration that is abbreviated
as follows: [Ca
2]i. Finally, calcium origin was investigated by imaging
intracellular Ca
2 activity in presence of 1 mol/l thapsigargin or 1 mmol/l
EGTA. Effects of ROS on depolarization were done in presence of the
antioxidant trolox (1 mmol/l) by stimulating islets with 30 mmol/l KCl. Before
islet measurement, background ﬂuorescence was recorded for both wave-
lengths in areas devoid of islets, and the data were subtracted from the
corresponding measurements of fura-2–loaded islets.
Insulin resecretion test. After antimycin or rotenone exposition (static
condition) for 30 min, islets were replaced for 30 min in 5.5 mmol/l glucose,
insulin was measured, and then islets were rinsed and re-exposed to 16.7
mmol/l glucose for the same lapse of time; de novo insulin secretion was
evaluated on supernatants.
Insulin radioimmunoassay. Insulin was measured by means of a radioim-
munoassay kit (Cis-Bio International, Gif-sur-Yvette, France) using
125I-la-
beled porcine insulin tracer and tube coated with anti-porcine guinea pig
antiserum. Rat insulin standard was obtained from Linco Research (St.
Charles, MO). The lower limit of the assays was 75 pmol/l with a variation
coefﬁcient of 6% within the assays and of 8% between the assays.
Lipid peroxidation determinations. Hydroperoxides in biological samples
were estimated using the Lipid Hydroperoxide Assay kit (Cayman; Alexis
Biochemicals). This method is based on lipid extraction into chloroform,
eliminating interference caused by hydrogen peroxide or endogenous ferric
ions.
Statistical analysis. Values are expressed as means  SE. The statistical
signiﬁcance of differences between two groups was determined by Student’s
t test, and multiple comparisons were made by ANOVA followed by Student-
Newman-Keuls test. For the regressions, a Pearson correlation matrix using
SYSTAT software was used, followed by a matrix of Bonferroni probabilities.
RESULTS
Glucose induces ROS production in isolated rat is-
lets. A glucose challenge (16.7 mmol/l) during 30-min
incubation triggered a threefold increase of ROS ﬂuores-
cence as shown in Fig. 1A. This ROS production was
accompanied by a classical GSIS (Fig. 1B). We then
investigated whether a causal link exists between these
two events by quenching ROS rise using an antioxidant. As
expected, ROS production was completely abolished by
trolox, a vitamin E analog (Fig. 1A). Strikingly, this was
associated with a complete blunting of GSIS, suggesting
the involvement of ROS in GSIS (Fig. 1B). To conﬁrm
these data, we performed perifusion experiments, which
allow a dynamic view of insulin secretion. As was the case
previously, the presence of the antioxidant induced a
pronounced and signiﬁcant reduction of GSIS (Fig. 1C).
We then investigated whether a dose response might be
established between ROS production and insulin secre-
tion. This was achieved in static incubation by gradual
antioxidant levels to modulate ROS production under
GSIS (Fig. 1D and E). Under these conditions, the regres-
sion linking ROS production to insulin secretion (r 
0.899) was highly signiﬁcant (P  0.001; Fig. 1F). More-
over, kinetics of both ROS production and insulin secre-
tion were measured under GSIS and revealed the ROS
elevation shown at 5 min coincided with the start of
insulin secretion under static conditions. A plateau was
maintained for both ROS production and insulin secretion
during the 30 min that lasted the experiment (Fig. 2A and
B). Altogether, these results indicated that ROS was pro-
duced under acute glucose stimulation and was required
for insulin secretion. Moreover insulin was dose depen-
dently released, reinforcing the fact that ROS could be an
important part of the in GSIS signaling.
mROS mimic GSIS. To test whether mROS have the
ability to mimic GSIS, speciﬁc mitochondrial blockers that
increase mROS production were used. Rotenone and
antimycin, complex I and III inhibitors, respectively, were
added to the 30-min static incubation with no glucose
challenge in basal glucose condition (5.5 mmol/l). The
concentrations (100 mol/l rotenone and 20 mol/l anti-
mycin) were chosen to mimic a similar ROS production to
that obtained with a 16.7 mmol/l glucose stimulus (Fig.
3A). Trolox (1 mmol/l) or 1 mmol/l glutathione reduced
ethyl ester cotreatment blunted the ROS ﬂuorescence (Fig.
3A) and the insulin release (Fig. 3B). To assess this
response in a dynamic model, perifusion experiments
were also conducted. The presence of the mitochondrial
blocker rotenone perfectly mimicked GSIS (Fig. 3C),
which was signiﬁcantly reduced in the presence of the
antioxidant trolox (Fig. 3C). To test our hypothesis in
static incubation, we coadministered an antioxidant in a
dose response–dependent manner. It consequently dimin-
ished ROS production (Fig. 3D and E). ROS production
was clearly correlated to insulin secretion (r  0.883), and
the regression was highly signiﬁcant (P  0.001; Fig. 3F).
To conﬁrm the mitochondrial origin of glucose-induced
ROS, cells were cotreated with 16.7 mmol/l glucose and
the mild uncoupler CCCP (1 mol/l), which makes it
possible to block the ATP rise without decreasing its level
(11). This uncoupler accelerates electron transit by dissi-
pating the H
 gradient, decreasing the probability of the
electrons reacting with oxygen and thus leading to the
ROS SIGNALING AND GSIS
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3A. In this case, insulin secretion was completely blunted
(Fig. 3B). Finally, the effects of rotenone and antimycin in
the presence of 16.7 mmol/l glucose had been tested: They
increased the ROS production and insulin secretion more
efﬁciently than 16.7 mmol/l glucose alone or mitochondrial
blockers alone (data not shown). These results suggest
that increasing glucose to 16.7 mmol/l (i.e., electron do-
nors) while partially inhibiting the mitochondrial respira-
tion (slowing down the electron transit) led to the greatest
ROS production, ﬁnally increasing insulin secretion.
NADH and ATP increases are not necessary for
mROS-induced insulin secretion. The results presented
in Fig. 1 suggested that quenching ROS was strikingly
enough to blunt insulin secretion. Because ATP and
NADH—two crucial products of glucose metabolism and
respiration—have been considered as main cellular trig-
gers for insulin secretion, we undertook a last set of
experiments to deﬁnitively rule out their involvement. As
shown in Fig. 4C and D, although both ATP and NADH
were highly signiﬁcantly increased, insulin secretion was
completely abolished when adding antioxidant as previ-
ously reported. In this case, only ROS enhancement was
completely blunted (Fig. 4A). In the reverse experiment,
using mitochondrial blocker 100 mol/l rotenone, a con-
centration that did not modify ATP and NADH concentra-
tions (Fig. 4C and D) but ensured mROS production (Fig.
4A), showed that insulin secretion was still stimulated
(Fig. 4B). In these experiments, it is noteworthy that
insulin secretion was achieved with almost identical levels
of ROS ﬂuorescence produced either by 16.7 mmol/l
glucose or by rotenone, regardless of the high or basal ATP
and NADH levels (Fig. 4A–D). Moreover, no correlation
was observed between ATP and NADH levels and insulin
secretion. These complementary results strongly suggest
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independently of these other products linked to glucose
metabolism.
Effect of quenching ROS production on intracellular
calcium proﬁles after glucose, mitochondrial blocker,
or KCl treatment. Switching the extracellular glucose
concentration from 5 to 16.7 mmol/l led to an increase in
[Ca
2]i. The subsequent addition of 1 mmol/l trolox led to
a marked fall in [Ca
2]i to basal level in the following 5
min, suggesting that ROS quenching led to impaired
[Ca
2]i mobilization (Fig. 5A). Switching the extracellular
glucose concentration from 5 mmol/l to 5 mmol/l plus 100
mol/l rotenone ﬁrst led to a transient fall in [Ca
2]i in the
ﬁrst 8 min, followed by a large sustained increase (Fig.
5B). The addition of the antioxidant trolox (1 mmol/l) to
rotenone completely abolished the [Ca
2]i mobilization
(Fig. 5B), showing that mROS production might impor-
tantly serve as signals mediating the necessary Ca
2
recruitment for insulin secretion. Finally, Fig. 5C and D
show one representative example of three experiments for
the [Ca
2]i mobilization under either 1 mmol/l EGTA
(chelating extracellular Ca
2 ions) or 1 mol/l thapsigar-
gin (irreversible inhibition of Ca
2 pumps from intracellu-
lar stores). Increasing the glucose concentration or adding
rotenone ﬁrst triggered a typical biphasic response; sec-
ond, the presence of EGTA (calcium-free medium) re-
sulted in a profound decrease of ﬂuorescence fura-2 ratio
340:380, i.e., intracellular calcium mobilization, for both
glucose and rotenone, suggesting the calcium might be
mainly of extracellular origin (Fig. 5C). Figure 5D shows
the complementary experiment using thapsigargin, which
did not suppress the massive increase of [Ca
2]i, whatever
D: Modulation of rotenone-induced ROS production and GSIS by gradual antioxidant doses. ROS-dependent response might be established with insulin
secretion in static incubation. Three independent experiments, n6 per group; ***P<0.001, rotenone 1 nmol/l trolox vs. rotenone 1mol/l trolox;
###P < 0.001, rotenone  1 mol/l trolox vs. rotenone  1 mmol/l trolox. F: In these conditions, the regression linking ROS production to insulin
secretion (r  0.883) was highly signiﬁcant P < 0.001. , vehicle; , glucose 16.7 mM; Œ, rotenone; , rotenone  trolox.
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FIG. 4. NADH and ATP increases are not necessary for mROS-induced insulin secretion. Ratio of either ROS production as measured with
H2-DCFDA (A), NADH (B), insulin secretion (C), or ATP (D) compared with basal condition (5.5 mmol/l glucose) in three independent
experiments, n  4 per group. A and C: Static islet incubation for 30 min in 16.7 mmol/l glucose cotreated with trolox abolished ROS production
and blunted insulin secretion; ***P < 0.001, glucose 16.7 vs. 5.5 mmol/l; ###P < 0.001, 16.7 mmol/l glucose  trolox vs. 16.7 mmol/l glucose alone.
B and D: Both NADH and ATP were increased, although insulin secretion was abolished when ROS were blunted; *P < 0.05 or **P < 0.001, 16.7
mmol/l glucose  trolox vs. 16.7 mmol/l glucose alone. Conversely, 100 mol/l rotenone (rot) stimulated ROS production and insulin secretion
(A and C), independently of NADH or ATP (B and D), which were unchanged compared with controls. ***P < 0.001, 5.5 mmol/l glucose  rotenone
vs. 5.5 mmol/l glucose; §§§P < 0.001 or §P < 0.05, 5.5 mmol/l glucose  rotenone vs. 5.5 mmol/l glucose  rotenone  trolox.
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biphasic rise disappeared in both cases, emphasizing that
the ﬁrst peak might required calcium of intracellular
origin. In the next experiment, we tested whether the ROS
scavenger trolox (1 mmol/l) would abrogate the calcium
effect of KCl. It had no inhibitory effect on KCl-induced
[Ca
2]i mobilization (Fig. 5E).
No toxic effects are present in the model used. To rule
out a putative damaging effect on membrane integrity due
to peroxidation and a nonspeciﬁc oxidative stress of ROS,
lipid peroxidation was evaluated. Hydroperoxide measure-
ments were conducted on glucose and pharmacologically
treated islets. No difference in peroxidation in the phar-
macologically treated groups compared with glucose was
observed (Fig. 6A). To deﬁnitively exclude a toxic effect,
-cells previously treated with the mitochondrial blockers
for 30 min were replaced in a fresh medium, and insulin
was reevaluated before and after a glucose challenge.
Under these conditions, only a slight insulin release was
detected in the fresh medium under basal conditions, and
the ability of glucose to stimulate insulin secretion was
totally maintained after the pharmacological treatments
(Fig. 6B). Altogether, these results exclude the possibility
of damaging effects of rotenone or antimycin on islets.
DISCUSSION
It is now accepted that small ﬂuctuations in the steady-
state concentration of ROS may play a role in intracellular
signaling (3,12). Their pivotal role in nutrient sensing is
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FIG. 5. Intracellular calcium proﬁles after glucose, mitochondrial blocker, or KCl
treatment. A: Intracellular calcium expressed as the ratio of fura-2 probe ﬂuores-
cence (340 nm/380 nm) from basal conditions (5 mmol/l glucose) to 16.7 mmol/l
glucose. Addition of the antioxidant trolox signiﬁcantly reverses the [Ca
2]i mobili-
zation classically observed with glucose concentration increase. C: The experiment
was repeated except that instead of raising glucose, 100 mol/l rotenone was added to
islets. Addition of rotenone ﬁrst led to a transient fall in [Ca
2]i the ﬁrst 8 min,
followed by a large and sustained increase. B: Investigation of calcium origin using 1
mmol/l EGTA after removal of Ca
2 from the extracellular bath solution. Increasing
the glucose concentration or adding rotenone ﬁrst triggered a typical biphasic
response, and the presence of EGTA resulted in a profound decrease of ﬂuorescence
fura-2 ratio 340:380 for both glucose and rotenone. D: Investigation of calcium origin
using 1 mol/l thapsigargin in islets treated with either 16.7 mmol/l glucose or 100
mol/l rotenone did not suppress the massive increase of [Ca
2]i. The experiment
shown is representative of three (glucose and mitochondrial blockers) or two (KCl)
with similar results.
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highlighted their requirement in hypothalamic glucose and
lipid sensing (5,6). Here, we expand the question to the
gold standard, and the main glucose-sensitive cell type, the
pancreatic -cells. The present results undoubtedly dem-
onstrate that glucose-induced mitochondrial ROS produc-
tion is an obligatory stimulus for insulin secretion.
In cells, mitochondria are the main source of oxidants.
Transient-accelerated electron transport on glucose stim-
ulation generates an H2O2 burst in many cell types, includ-
ing the -cells (13). Metabolism of substrates leads to
reduced formation of equivalents (NADH and FADH2) that
predispose to increased mROS through a direct effect on
the electron-transfer chain (14). Preceding studies point to
the crucial role of H2O2, which either acts as a transduc-
tion signal, normally coupling glucose metabolism to insu-
lin secretion, or interrupts it depending on its
concentration (7,15–17).
In this study, the pharmacological approach was highly
justiﬁed because transient, moderate, and reversible
mROS production was required (11). Currently, no genetic
construction, even through a conditional control, permits
this ﬁne regulation. In this study, we not only found that
insulin is released in a mROS dose-dependent fashion but
also that mROS are absolutely required for the secretion,
using different and complementary pharmacological ma-
nipulations. Our results are coherent and convergent, they
moreover are consistent with those of Collins and col-
leagues (7), who demonstrated that glucose increases
intracellular accumulation of H2O2, stimulating insulin
secretion in both isolated mouse islets and INS-1(832/13)
cells. These results enhance the emerging view that glu-
cose induces a transient and moderate H2O2 production in
-cells. This light production is made possible because a
ﬁne adapted system makes it possible to regulate the
process (antioxidant defenses) (7). The discrepancies ob-
served in the levels of ROS (either increase or decrease) in
-cells exposed to glucose reported in numerous studies
(15,18,19) might be explained by the different exposure
times and glucose-culture conditions; it now appears
clearly that cyclic ROS production occurs in a time-
dependent manner (7). One of the regulating systems
operates through the nucleotide nicotinamide transhydro-
genase, rapidly and actively regenerating redox balance
through the supply of NADPH, which simultaneously
dissipates the proton gradient (20). The light and neces-
sary production of ROS for insulin secretion during glu-
cose exposure might rapidly become inadequate when
time exposure is no longer controlled, due to the unbal-
ance of the redox-status regeneration, a process that is
exacerbated in culture conditions.
The present data clearly point out the importance of
ROS from mitochondrial origin. First, mitochondrial ROS
mimic the glucose effect. Using mitochondrial blockers
that increase mROS at a level similar to that of glucose,
insulin secretion was identical to that produced by glu-
cose. Second, no extramitochondrial ROS was detected in
glucose and CCCP-cotreated -cells. This compound in-
creases respiration and diminishes mROS generation. If
glucose has the ability to induce ROS production indepen-
dently of the mitochondria, it might be detected in a
condition that only abolishes mitochondrial ROS produc-
tion (CCCP). This means that ROS produced in the time
course of glucose metabolism might be solely due to
mitochondria in our detection conditions. It strongly sug-
gests that mROS are robust stimulators of insulin secre-
tion independently of other products linked to glucose
metabolism, such as NADH or ATP. Thus, even in the
presence of an NADH or ATP rise, GSIS was systematically
B
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FIG. 6. Islet preservation under the different mitochondrial treatments.
A: To exclude a damaging and nonspeciﬁc oxidative stress, lipid peroxi-
dation was evaluated. Hydroperoxides were evaluated on islets treated in
static incubation for 30 min with 100 mol/l rotenone, 1 mol/l CCCP, or
20 mol/l antimycine compared with basal conditions, 5.5 mmol/l glucose.
No difference in these groups compared with glucose was observed. B:
Insulin resecretion after the 100 mol/l rotenone or 20 mol/l antimycin
treatment consisted to expose islets to GSIS after they were stimulated
with the mitochondrial blockers for 30 min and insulin was measured in
the milieu. They were replaced in basal glucose (5.5 mmol/l) for 30 min
further, and insulin was reevaluated before a GSIS was done. In these
conditions, insulin release was absent in the milieu in basal conditions,
and the ability of glucose to restimulate insulin secretion was totally
maintained after the pharmacological treatments. Three independent
experiments, n  6; ***P < 0.001, glucose 16.7 vs. 5.5 mmol/l. Bars
represent SE in all ﬁgures. They were not represented for perifused-islet
experiments. Ant, antimycin; rot, rotenone.
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nately, NADPH, which is a potential mediator of GSIS, was
not detectable in our experimental conditions. We cannot
exclude its level changed by the manipulations used here,
maybe independently of ROS.
Mitochondrial blockers triggering insulin release in our
study are in contradiction with the results of Collins and
colleagues (7), who conclude that the ROS might not be of
mitochondrial origin. The difference is the concentrations
we used, and as a result, the sole difference is based on
ATP levels that were unchanged in our model but down-
regulated in their study. The downregulation of ATP
content suggests a strong inhibition of oxidative phosphor-
ylation and might explain the discrepancies between the
two studies. The additive experiments on [Ca
2]i suggest
mROS production being of importance, because the addi-
tion of the antioxidant trolox to either glucose or rotenone
completely abolished the Ca
2 mobilization. The results of
Fig. 5C and D suggest mROS are important for the biphasic
effect on [Ca
2]i because they totally mimicked the Ca
2
mobilization proﬁle seen with glucose. The exploration of
the calcium origin suggests the ﬁrst peak of Ca
2 might be
of intracellular origin even through the second massive
increase appears to be of extracellular one. These results
are in concordance with part of the study of Krippeit-
Drews et al. (17) who had extensively studied the origin of
Ca
2 under a concentrated H2O2 stimulus. Whether the
Ca
2 inﬂux might be due to ATP-sensitive K
 channel
(KATP channel)-induced depolarization was undertaken in
this study. In this case, H2O2 caused the opening of the
channel (the sulfonylurea tolbutamide was able to reverse
the effect), and the sustained extracellular Ca
2 inﬂux was
shown to be due to a direct activation of L-type Ca
2
channels in mouse -cells (21–23) and recently in dopa-
mine neurons (24). These results are not in favor of the
participation of the KATP channels in the second sustained
increase of [Ca
2]i. Moreover, even if ATP levels were
critical in these studies, here, the pharmacological doses
of rotenone or antimycin A used were without effect on
ATP levels when compared with glucose controls (5.5
mmol/l).
The -cell depolarization is a crucial event to activate
the insulin exocytotic machinery in the early phase of
GSIS, and that is the reason why the ROS dependence of
depolarization-stimulated Ca
2 mobilization was investi-
gated. Our results indicate that mROS-stimulated insulin
secretion is an extracellular Ca
2-dependent process, sug-
gesting that mROS may be involved in Ca
2 inﬂux. In
contrast, the evidence that the exogenous antioxidant
trolox does not inhibit KCl-induced [Ca
2]i increase sug-
gests that the voltage pathway works independently of the
mROS pathway. These last results are in perfect concor-
dance with those of Collins and colleagues, who did not
detect an inhibition of the antioxidants on KCl-induced
insulin release. Our results, combined with those of Col-
lins and colleagues, reinforce the idea that mROS belong
to the essential coupling factors for stimulating insulin
secretion.
Moreover, in our experiments, putative toxic effects
can be ruled out; both results of lipid peroxidation and
functional tests (GSIS) were in keeping with intact islet
preservation. These data support that mROS signaling is
of prime importance, although the underlying mecha-
nism(s) leading to insulin secretion is(are) far from
being identiﬁed.
Strikingly, one is led to think that the classical ATP
elevation-induced KATP closure is not as determinant as
has been suggested. Different putative targets might be
involved, linking mROS to insulin production. First, the
mitochondria itself: mitochondrial Ca
2 rise is in part
H2O2 sensitive and absolutely required for insulin secre-
tion (16,17). Second, the channels, which are involved in
membrane depolarization (25). For example, transient
receptor potential channels may also be potential targets
because many of them are H2O2 sensitive (26–31).
Altogether, these data point to the complex involvement
of mitochondrial metabolism in GSIS. Moreover, the con-
sensual model of ATP as a coupling factor of nutrient-
induced insulin secretion is no longer as evident as
previously accepted. Finally, our ﬁndings support the idea
that mROS are obligatory signaling pathways of GSIS. The
mROS appear as the necessary balanced signal between
NADH supply on one hand and the ATP production on the
other hand. The understanding of this signaling might be
of prime importance in nutritional care of energy balance
and health.
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